Clinical Trials in Austin

Showing 9761-9780 of 11,561 trials

The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects

NCT02243241

Evaluate the effect of multiple doses (once daily for 3 days each of HYD 80, 120, and 160 mg tablets) on the QT/QTc interval.

Healthy

Purdue Pharma LP208 participantsStarted Nov 2012

Austin, Texas, United States

COMPLETEDPhase 3< 1 mile

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

NCT00378612

ACROSS-Cypher® is a prospective, multi-center, open label, single arm study of the Cypher® sirolimus eluting coronary stent in native total coronary occlusion revascularization. The primary endpoint is binary angiographic restenosis at 6 months. The TOSCA-1 trial will be used as the historical control. The hypothesis is that compared with TOSCA-1 patients who were treated with the heparin-coated Palmaz Schatz stent, treatment with the Cypher® sirolimus eluting coronary stent will result in a \>50% relative reduction in 6 month restenosis within the treated segment of the target vessel.

Coronary Occlusions

Sunil Rao200 participantsStarted Jun 2005

La Jolla, California, United States • La Jolla, California, United States • Washington D.C., District of Columbia, United States +13 more locations

The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Find Trials by Condition in Austin

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

ADNI: Alzheimer's Disease Neuroimaging Initiative

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults

A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis

Social and Communication Outcomes for Young Children With Autism

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.